Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Sulfony lated acetylglucosamine medicinal composition and its use

A technology of sulfonylated acetamido and polysulfonylated acetamido is applied in the application field of preparing medicine for treating degenerative osteoarthropathy, and achieves the effects of strong hygroscopicity, reducing the degree of hygroscopicity, and delaying the progress of degenerative changes

Inactive Publication Date: 2006-02-08
ZHUHAI CLEANSTAR CLEANING TECH
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there is no report about the pharmaceutical composition of sulfonylated acetylglucosamine and hydroxylysine for the treatment of degenerative osteoarthritis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] Embodiment 1 (oral capsule and tablet)

[0053] Under dry environmental conditions, weigh each component according to the proportion (by weight), i.e., 70% sulfonylated acetylglucosamine oligosaccharide, 20% acetylglucosamine oligopolyglucosamine, and 10% hydroxylysine, and mix well According to conventional methods, granulate, encapsulate moisture-proof, pack in capsules, each capsule contains 0.5g of medicine, or add appropriate amount of compressive agent to press into tablets, apply moisture-proof film, each tablet contains 0.5g of medicine, and the usage is oral administration of 0.5g, 2 -4 times / day.

Embodiment 2

[0054] Embodiment 2 (oral capsule and tablet)

[0055] The preparation method is the same as that of Example 1, only the distribution ratio of each component is changed, that is, 90% of sulfonylated acetylglucosamine, 1% of glucosamine and 9% of hydroxylysine.

Embodiment 3

[0056] Embodiment 3 (oral capsule and tablet)

[0057] The preparation method is the same as in Example 1, only the distribution ratio of each component is changed, that is, 1% of oligosulfonylated acetylglucosamine, 90% of oligoacetylglucosamine, and 9% of hydroxylysine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a sulfonyl acetylglucosamine medicine composition and its application in preparation of medicine for curing retrograde osteoarthropathy. Said medicine composition is formed from 1-90% of sulfonyl acetylglucosamine, 90-1% of acetylglucosamine and 1-10% of hydroxylysine. Said invented oral preparation or fluid infusion preparation has the notable therapeutical effect for curing the diseases of senile osteoarthropathy, scapulohumeral periarthritis, articular cartilage synovial injury by collision, cartilage synovial injury and chondronecrosis of head of femur, cartilaginous synvium restoration of rheumatoid arthritis in stable stage and fatigue osteoarthritis, etc.

Description

technical field [0001] The invention relates to a sulfonylated acetylglucosamine pharmaceutical composition and application thereof. More specifically, the present invention relates to a pharmaceutical composition of sulfonylated acetylglucosamine and its application in the preparation of medicines for treating degenerative osteoarthritis. Background technique [0002] Everyone knows the phenomenon of "legs get old first when people get old". Physiologically, cartilage degenerative changes begin to occur after the age of 30, and most people begin to have symptoms of joint discomfort after the age of 40, especially when the joints are subjected to a strong impact when long jumping or jumping from a high place. The old man has a narrow stride, and the clinical manifestations are joint pain and stumbling, narrowing of the bone joint space, and obvious joint pain when going up and down stairs. In the past, it was believed that this kind of systemic bone and joint degeneration ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7008A61P19/08
Inventor 王浦林
Owner ZHUHAI CLEANSTAR CLEANING TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com